Systematic Review and Meta-analysis of the Efficacy of Oral Medications Compared with Placebo Treatment in the Management of Postherpetic Neuralgia

Aims: To conduct a systematic review to determine the efficacy of oral medications for the management of postherpetic neuralgia (PHN). Methods: Three electronic databases were searched: Cochrane Library (up to 7 July 2015), MEDLINE via PubMed (from 1950 to 7 July 2015), and Web of Science (1864 to 7 July 2015). Studies were limited to double-blind, placebo-controlled, randomized controlled trials on oral medications used to treat PHN. Risk of bias was independently assessed in duplicate. Results: A total of 256 abstracts were screened by two independent reviewers and 26 full-text articles were assessed for eligibility. A total of 11 relevant articles were selected for inclusion. These 11 articles were included in a qualitative synthesis and 8 were included in a meta-analysis; however, all the included studies had a high or unclear risk of bias and the interventions were heterogenous. In a subgroup analysis of five studies, anticonvulsants (gabapentin, pregabalin, and divalproex sodium) were found to improve short-term pain intensity (standardized mean difference [SMD] = −0.484, 95% confidence interval [CI] = −0.622 to −0.346, P < .001). In a second subgroup analysis of five studies, it was found that patients taking anticonvulsants were 2.5 times as likely to have a 50% or more reduction in pain after treatment than patients taking placebo. Conclusion: This review has provided favorable but low-quality evidence to support the use of anticonvulsants for PHN. Although statistically significant effects were observed for posttreatment pain and the percent of responders, the number of studies in each subgroup analysis for anticonvulsants was small and the included studies had high or unclear risk of bias. Further high-quality methodologic studies are needed to explore the effects of orally administered anticonvulsants for PHN.

anticonvulsants; antidepressants; herpes zoster; opioids; postherpetic neuralgia

1. Christo PJ, Hobelmann G, Maine DN. Post-herpetic neuralgia in older adults: Evidence-based approaches to clinical management. Drugs Aging 2007;24:1–19.

2. Mahn F, Baron R. Postherpetic neuralgia [article in German]. Klin Monbl Augenheilkd 2010;227:379–383.

3. Jensen TS. Anticonvulsants in neuropathic pain: Rationale and clinical evidence. Eur J Pain 2002;6:61–68.

4. Edelsberg JS, Lord C, Oster G. Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother 2011;45:1483–1490.

5. Sansone RA, Sansone LA. Tramadol: Seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont) 2009;6:17–21.

6. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008.

7. Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC. Pregabalin for postherpetic neuralgia: Placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief. J Pain 2008;9:1006–1017.

8. Rice AS, Maton S. Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001;94:215–224.

9. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: A randomized,placebo-controlled trial. Neurology 2002;59:1015–1021.

10. Watson CP, Evans RJ, Reed K, Merskey H, Goldsmith L, Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982;32:671–673.

11. Kishore-Kumar R, Max MB, Schafer SC, et al. Desipramine relieves postherpetic neuralgia. Clin Pharmacol Ther 1990;47: 305–312.

12. Cochran WG. The combination of estimates from different experiments. Biomimetics 1954;10:101–129.

13. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–1558.

14. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998;280: 1837–1842.

15. Sabatowski R, Gálvez R, Cherry DA, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial. Pain 2004;109:26–35.

16. van Seventer R, Feister HA, Young JP Jr, Stoker M, Versavel M, Rigaudy L. Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: A 13-week, randomized trial. Curr Med Res Opin 2006;22:375–384.

17. Max MB, Schafer SC, Culnane M, Smoller B, Dubner R, Gracely RH. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38:1427–1432.

18. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in postherpetic neuralgia: A randomized, double-blind, placebo-controlled trial. Pain 2003;104:323–331.

19. Kochar DK, Garg P, Bumb RA, et al. Divalproex sodium in the management of post-herpetic neuralgia: A randomized double-blind placebo-controlled study. QJM 2005;98:29–34.

20. Meng FY, Zhang LC, Liu Y, et al. Efficacy and safety of gabapentin for treatment of postherpetic neuralgia: A meta-analysis of randomized controlled trials. Minerva Anestesiol 2014; 80:556–567.

21. Snedecor SJ, Sudharshan L, Cappelleri JC, et al. Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions. Int J Clin Pract 2014;68:900–918.

22. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: A Cochrane review. J Neurol Neurosurg Psychiatry 2010;81: 1372–1373.

23. Eddy CM, Rickards HE, Cavanna AE. The cognitive impact of antiepileptic drugs. Ther Adv Neurol Disord 2011;4:385–407.

24. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL. Nortriptyline and gabapentin, alone and in combination for neuropathic pain: A double-blind, randomised controlled crossover trial. Lancet 2009;374:1252–1261.